Notably, the expression of DMT1 and TFR1 in breast cancer tissues was significantly higher than that in paired control samples (Fig. 6e, f), and high expression of DMT1 and TFR1 was correlated with poor survival in breast cancer patients in an independent cohort (Fig. 6g, h). Here, SLC11A2 is linked to breast carcinoma.